American College of Radiation Oncology | Strategic Alliance Partners

OS and PFS rates were positive as demonstrated by real-world data in patients given SBRT for oligometastatic ovarian cancer.

Theranostics, a technique that combines traditional medication with diagnostics, is “limitless”, according to Brandon Mancini, MD, MBA, FACRO.

J. Isabelle Choi, MD, outlined evidence-based strategies for radiation dose escalation in locoregionally advanced breast cancer.

Sunil Dutta, MD, discusses how whole-breast radiation or systemic therapy is responsible for controlling low-volume disease.

Due to certain errors in the 2026 PFS Final Rule pre-publication, ACRO has issued a statement while awaiting the publication of the 2026 HOPPS Final Rule.

ACR-accredited radiation oncology practices will now be eligible to apply for an advanced quality recognition program developed by ACRO and RSS.

As noted in the letters, "ACRO’s comments seek to ensure ongoing access to high-quality, state-of-the-art radiation oncology services."

ACRO's Accreditation Program has completed and passed its annual surveillance by the International Standards Organization.